Page last updated: 2024-10-18

dalteparin and Bronchitis

dalteparin has been researched along with Bronchitis in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salameh, A1
Klein, M1
Klein, N1
Pfeiffer, D1
Dähnert, I1
Dhein, S1
Krasnowska, M1
Kwaśniewski, A1
Rabczyński, J1
Kuryszko, JJ1

Other Studies

2 other studies available for dalteparin and Bronchitis

ArticleYear
Coughing into the darkness.
    Lancet (London, England), 2011, May-14, Volume: 377, Issue:9778

    Topics: Adult; Anticoagulants; Bronchitis; Carotid Artery, Internal; Constriction, Pathologic; Cough; Drug A

2011
[The influence of heparin on the course of bronchitis experimentally provoked by sulfur dioxide in rats in evaluation of lung histology and cytology of bronchial alveolar lavage fluid].
    Pneumonologia i alergologia polska, 1997, Volume: 65, Issue:1-2

    Topics: Administration, Inhalation; Animals; Bronchitis; Bronchoalveolar Lavage Fluid; Fibrinolytic Agents;

1997